Literature DB >> 17652525

Persistence of West Nile virus-specific antibodies in viremic blood donors.

Harry E Prince1, Leslie H Tobler, Cindy Yeh, Nelly Gefter, Brian Custer, Michael P Busch.   

Abstract

We evaluated West Nile virus (WNV) antibody persistence by using follow-up plasma samples from 35 blood donors who made viremic donations in 2005. At 26 to 34 days of follow-up, all of the donors (n = 33) were positive for WNV immunoglobulin M (IgM), IgA, and IgG. At 1-year of follow-up, 17% of the donors (n = 23) were positive for WNV IgM, 57% were positive for WNV IgA, and 100% were positive for WNV IgG.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17652525      PMCID： PMC2043320          DOI： 10.1128/CVI.00233-07

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  7 in total

1.  West Nile virus among blood donors in the United States, 2003 and 2004.

Authors:  Susan L Stramer; Chyang T Fang; Gregory A Foster; Annette G Wagner; Jaye P Brodsky; Roger Y Dodd
Journal:  N Engl J Med       Date:  2005-08-04       Impact factor: 91.245

2.  Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors.

Authors:  Harry E Prince; Leslie H Tobler; Mary Lapé-Nixon; Gregory A Foster; Susan L Stramer; Michael P Busch
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

3.  Evaluation of a West Nile virus immunoglobulin A capture enzyme-linked immunosorbent assay.

Authors:  Harry E Prince; Mary Lapé-Nixon
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

Review 4.  West Nile virus: a primer for the clinician.

Authors:  Lyle R Petersen; Anthony A Marfin
Journal:  Ann Intern Med       Date:  2002-08-06       Impact factor: 25.391

5.  Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing.

Authors:  Michael P Busch; Sally Caglioti; Eugene F Robertson; Joan D McAuley; Leslie H Tobler; Hany Kamel; Jeffrey M Linnen; Venkatakrishna Shyamala; Peter Tomasulo; Steven H Kleinman
Journal:  N Engl J Med       Date:  2005-08-04       Impact factor: 91.245

6.  Performance of immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays using a West Nile virus recombinant antigen (preM/E) for detection of West Nile virus- and other flavivirus-specific antibodies.

Authors:  Wayne R Hogrefe; Ronald Moore; Mary Lape-Nixon; Michael Wagner; Harry E Prince
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

7.  Persistence of virus-reactive serum immunoglobulin m antibody in confirmed west nile virus encephalitis cases.

Authors:  John T Roehrig; Denis Nash; Beth Maldin; Anne Labowitz; Denise A Martin; Robert S Lanciotti; Grant L Campbell
Journal:  Emerg Infect Dis       Date:  2003-03       Impact factor: 6.883
  7 in total
  17 in total

Review 1.  West Nile virus in the transfusion setting with a special focus on Italian preventive measures adopted in 2008-2012 and their impact on blood safety.

Authors:  Simonetta Pupella; Giulio Pisani; Karen Cristiano; Liviana Catalano; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2013-10-23       Impact factor: 3.443

Review 2.  West Nile Virus in Europe and Safety of Blood Transfusion.

Authors:  Giulio Pisani; Karen Cristiano; Simonetta Pupella; Giancarlo Maria Liumbruno
Journal:  Transfus Med Hemother       Date:  2016-05-10       Impact factor: 3.747

3.  West Nile virus IgM and IgG antibodies three years post- infection.

Authors:  A Papa; A Anastasiadou; M Delianidou
Journal:  Hippokratia       Date:  2015 Jan-Mar       Impact factor: 0.471

Review 4.  West Nile virus state of the art report of MALWEST Project.

Authors:  Andriani Marka; Alexandros Diamantidis; Anna Papa; George Valiakos; Serafeim C Chaintoutis; Dimitrios Doukas; Persefoni Tserkezou; Alexios Giannakopoulos; Konstantinos Papaspyropoulos; Eleni Patsoula; Evangelos Badieritakis; Agoritsa Baka; Maria Tseroni; Danai Pervanidou; Nikos T Papadopoulos; George Koliopoulos; Dimitrios Tontis; Chrysostomos I Dovas; Charalambos Billinis; Athanassios Tsakris; Jenny Kremastinou; Christos Hadjichristodoulou; Nikolaos Vakalis; Evdokia Vassalou; Spyridoula Zarzani; Athanassios Zounos; Katerina Komata; Georgios Balatsos; Stavroula Beleri; Anastasia Mpimpa; Vasilios Papavasilopoulos; Ioannis Rodis; Grigorios Spanakos; Nikolaos Tegos; Vasiliki Spyrou; Zisis Dalabiras; Periklis Birtsas; Labrini Athanasiou; Maria Papanastassopoulou; Charalambos Ioannou; Christos Athanasiou; Christos Gerofotis; Elpida Papadopoulou; Theodolinta Testa; Ourania Tsakalidou; George Rachiotis; Nikolaos Bitsolas; Zissis Mamouris; Katerina Moutou; Theologia Sarafidou; Konstantinos Stamatis; Konstantina Sarri; Sotirios Tsiodras; Theano Georgakopoulou; Marios Detsis; Maria Mavrouli; Anastasia Stavropoulou; Lida Politi; Georgia Mageira; Varvara Christopoulou; Georgia Diamantopoulou; Nikolaos Spanakis; Georgia Vrioni; Evangelia-Theofano Piperaki; Kornilia Mitsopoulou; Ilias Kioulos; Antonios Michaelakis; Ioannis Stathis; Ioannis Tselentis; Anna Psaroulaki; Maria Keramarou; Dimosthenis Chochlakis; Yeorgios Photis; Maria Konstantinou; Panagiotis Manetos; Stylianos Tsobanoglou; Spyros Mourelatos; Vasilis Antalis; Panagiotis Pergantas; Georgios Eleftheriou
Journal:  Int J Environ Res Public Health       Date:  2013-12-02       Impact factor: 3.390

5.  Antibody Responses to Zika Virus Infections in Environments of Flavivirus Endemicity.

Authors:  Sarah L Keasey; Christine L Pugh; Stig M R Jensen; Jessica L Smith; Robert D Hontz; Anna P Durbin; Dawn M Dudley; David H O'Connor; Robert G Ulrich
Journal:  Clin Vaccine Immunol       Date:  2017-04-05

6.  Chikungunya virus RNA and antibody testing at a National Reference Laboratory since the emergence of Chikungunya virus in the Americas.

Authors:  Harry E Prince; Brent L Seaton; Jose L Matud; Hollis J Batterman
Journal:  Clin Vaccine Immunol       Date:  2014-12-24

Review 7.  West Nile virus.

Authors:  Shannan L Rossi; Ted M Ross; Jared D Evans
Journal:  Clin Lab Med       Date:  2010-03       Impact factor: 1.935

8.  Persistence of West Nile virus in the central nervous system and periphery of mice.

Authors:  Kim K Appler; Ashley N Brown; Barbara S Stewart; Melissa J Behr; Valerie L Demarest; Susan J Wong; Kristen A Bernard
Journal:  PLoS One       Date:  2010-05-14       Impact factor: 3.240

9.  Frequency of missed cases of probable acute West Nile virus (WNV) infection when testing for WNV RNA alone or WNV immunoglobulin M alone.

Authors:  Harry E Prince; Jan Calma; Tiffany Pham; Brent L Seaton
Journal:  Clin Vaccine Immunol       Date:  2009-02-18

Review 10.  Progress on the development of therapeutics against West Nile virus.

Authors:  Michael S Diamond
Journal:  Antiviral Res       Date:  2009-06-06       Impact factor: 5.970
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.